Free Trial
→ Warren Buffett Issues Cryptic Warning on U.S. Dollar (From Banyan Hill Publishing) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Allurion Technologies, Inc. stock logo
ALUR
Allurion Technologies
$2.17
-1.1%		$2.57
$1.98
▼
$20.00
$17M-0.4651,421 shs33,862 shs
Biotricity, Inc. stock logo
BTCY
Biotricity
$0.73
-0.6%		$0.51
$0.19
▼
$0.83
$18.18M1.1937,641 shs7,183 shs
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
$1.21
+4.3%		$1.27
$0.40
▼
$1.65
$14.64M2.281.58 million shs285,426 shs
Nuwellis, Inc. stock logo
NUWE
Nuwellis
$4.18
-0.7%		$7.44
$3.74
▼
$175.98
$3.80M0.18203,158 shs18,749 shs
7 Energy Stocks to Buy and Hold Forever Cover
7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Allurion Technologies, Inc. stock logo
ALUR
Allurion Technologies
-0.69%-1.72%-15.76%-13.05%-86.03%
Biotricity, Inc. stock logo
BTCY
Biotricity
-0.62%+5.10%+34.30%+39.46%+97.07%
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
+4.31%0.00%-9.02%+66.69%+8.04%
Nuwellis, Inc. stock logo
NUWE
Nuwellis
-0.71%-14.34%-24.00%-64.34%-91.11%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Allurion Technologies, Inc. stock logo
ALUR
Allurion Technologies
$2.17
-1.1%		$2.57
$1.98
▼
$20.00
$17M-0.4651,421 shs33,862 shs
Biotricity, Inc. stock logo
BTCY
Biotricity
$0.73
-0.6%		$0.51
$0.19
▼
$0.83
$18.18M1.1937,641 shs7,183 shs
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
$1.21
+4.3%		$1.27
$0.40
▼
$1.65
$14.64M2.281.58 million shs285,426 shs
Nuwellis, Inc. stock logo
NUWE
Nuwellis
$4.18
-0.7%		$7.44
$3.74
▼
$175.98
$3.80M0.18203,158 shs18,749 shs
7 Energy Stocks to Buy and Hold Forever Cover
7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Allurion Technologies, Inc. stock logo
ALUR
Allurion Technologies
-0.69%-1.72%-15.76%-13.05%-86.03%
Biotricity, Inc. stock logo
BTCY
Biotricity
-0.62%+5.10%+34.30%+39.46%+97.07%
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
+4.31%0.00%-9.02%+66.69%+8.04%
Nuwellis, Inc. stock logo
NUWE
Nuwellis
-0.71%-14.34%-24.00%-64.34%-91.11%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Allurion Technologies, Inc. stock logo
ALUR
Allurion Technologies
2.50
Moderate Buy$22.83954.66% Upside
Biotricity, Inc. stock logo
BTCY
Biotricity
2.00
HoldN/AN/A
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
3.00
Buy$2.0065.29% Upside
Nuwellis, Inc. stock logo
NUWE
Nuwellis
3.00
BuyN/AN/A

Current Analyst Ratings Breakdown

Latest NUWE, ALUR, BTCY, and IINN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/12/2025
Allurion Technologies, Inc. stock logo
ALUR
Allurion Technologies
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		UpgradeHold
(Data available from 9/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Allurion Technologies, Inc. stock logo
ALUR
Allurion Technologies
$19.92M0.84N/AN/A($30.08) per share-0.07
Biotricity, Inc. stock logo
BTCY
Biotricity
$12.06M1.50N/AN/A($1.30) per share-0.56
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
N/AN/AN/AN/A$0.34 per shareN/A
Nuwellis, Inc. stock logo
NUWE
Nuwellis
$8.74M0.43N/AN/A$62.71 per share0.07
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Allurion Technologies, Inc. stock logo
ALUR
Allurion Technologies
-$7.20M-$12.53N/AN/AN/A-158.30%N/A-59.91%11/12/2025 (Estimated)
Biotricity, Inc. stock logo
BTCY
Biotricity
-$14.09M-$0.21N/A∞N/A-80.42%N/A-188.47%11/13/2025 (Estimated)
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
-$11.05MN/A0.00∞N/AN/AN/AN/AN/A
Nuwellis, Inc. stock logo
NUWE
Nuwellis
-$11.16M-$35.36N/AN/AN/A-176.45%-1,424.01%-187.69%11/10/2025 (Estimated)

Latest NUWE, ALUR, BTCY, and IINN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/19/2025Q2 2025
Allurion Technologies, Inc. stock logo
ALUR
Allurion Technologies
-$0.65-$0.57+$0.08-$1.28$6.20 million$3.38 million
8/12/2025Q2 2025
Nuwellis, Inc. stock logo
NUWE
Nuwellis
-$0.45-$60.99-$60.54-$60.99$2.20 million$1.73 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Allurion Technologies, Inc. stock logo
ALUR
Allurion Technologies
N/AN/AN/AN/AN/A
Biotricity, Inc. stock logo
BTCY
Biotricity
N/AN/AN/AN/AN/A
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
N/AN/AN/AN/AN/A
Nuwellis, Inc. stock logo
NUWE
Nuwellis
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Allurion Technologies, Inc. stock logo
ALUR
Allurion Technologies
N/A
2.02
1.70
Biotricity, Inc. stock logo
BTCY
Biotricity
N/A
0.23
0.10
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
0.09
2.02
1.89
Nuwellis, Inc. stock logo
NUWE
Nuwellis
N/A
2.16
1.64

Institutional Ownership

CompanyInstitutional Ownership
Allurion Technologies, Inc. stock logo
ALUR
Allurion Technologies
21.39%
Biotricity, Inc. stock logo
BTCY
Biotricity
3.89%
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
12.72%
Nuwellis, Inc. stock logo
NUWE
Nuwellis
3.13%

Insider Ownership

CompanyInsider Ownership
Allurion Technologies, Inc. stock logo
ALUR
Allurion Technologies
22.40%
Biotricity, Inc. stock logo
BTCY
Biotricity
10.10%
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
29.40%
Nuwellis, Inc. stock logo
NUWE
Nuwellis
20.08%
CompanyEmployeesShares OutstandingFree FloatOptionable
Allurion Technologies, Inc. stock logo
ALUR
Allurion Technologies
5017.76 million6.02 millionOptionable
Biotricity, Inc. stock logo
BTCY
Biotricity
4024.91 million22.08 millionOptionable
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
2012.62 million8.91 millionNot Optionable
Nuwellis, Inc. stock logo
NUWE
Nuwellis
70900,000722,000Not Optionable

Recent News About These Companies

Nuwellis announces NIH awarded $3M multi-year grant to KBT
September 9, 2025  |  msn.comhttps://www.msn.com/en-us/health/other/nuwellis-announces-nih-awarded-3m-multi-year-grant-to-kbt/ar-AA1McFSF
Nuwellis secures NIH grant to advance pediatric kidney device
September 9, 2025  |  massdevice.comhttps://www.massdevice.com/nuwellis-secures-nih-grant-to-advance-pediatric-kidney-device/
Nuwellis’ Vivian Receives $3 Million NIH Grant to Accelerate Pediatric Platform and Strengthen Fluid-Management Portfolio
September 9, 2025  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/nuwellis-vivian-receives-3-million-nih-grant-to-accelerate-pediatric-platform-and-strengthen-fluid-management-portfolio-1035127937
Nuwellis' Vivian Receives $3 Million NIH Grant to Accelerate Pediatric Platform and Strengthen Fluid-Management Portfolio
September 9, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/09/09/3146982/26106/en/nuwellis-vivian-receives-3-million-nih-grant-to-accelerate-pediatric-platform-and-strengthen-fluid-management-portfolio.html
Nuwellis introduces 24-hour circuit for Aquadex therapy in the U.S.
September 4, 2025  |  msn.comhttps://www.msn.com/en-us/health/other/nuwellis-introduces-24-hour-circuit-for-aquadex-therapy-in-the-us/ar-AA1LSCmU
Nuwellis Introduces New 24-Hour Aquadex™ Circuit to Support Hospital-Based Outpatient and Short-Term Fluid Management
September 4, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/09/04/3144489/26106/en/nuwellis-introduces-new-24-hour-aquadex-circuit-to-support-hospital-based-outpatient-and-short-term-fluid-management.html
Nuwellis receives FDA 510k clearance for new dELC
August 22, 2025  |  msn.comhttps://www.msn.com/en-us/public-safety-and-emergencies/general/nuwellis-receives-fda-510k-clearance-for-new-delc/ar-AA1KXDh8
Nuwellis Receives FDA 510(k) Clearance for New Dual Lumen Extended Length Catheter
August 21, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/08/21/3137110/26106/en/nuwellis-receives-fda-510-k-clearance-for-new-dual-lumen-extended-length-catheter.html
Nuwellis, Inc.: Nuwellis Signs Letter of Intent to Explore Acquisition of Rendiatech Ltd., A Real-Time Fluid Monitoring Company
August 19, 2025  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2025-08/66215923-nuwellis-inc-nuwellis-signs-letter-of-intent-to-explore-acquisition-of-rendiatech-ltd-a-real-time-fluid-monitoring-company-399.htm
Nuwellis signs LOI to explore acquisition of Rendiatech
August 19, 2025  |  msn.comhttps://www.msn.com/en-us/health/other/nuwellis-signs-loi-to-explore-acquisition-of-rendiatech/ar-AA1KOjNS
Nuwellis signs letter of intent to acquire Rendiatech
August 19, 2025  |  msn.comhttps://www.msn.com/en-us/technology/general/nuwellis-signs-letter-of-intent-to-acquire-rendiatech/ar-AA1KNLmp
Nuwellis Signs Letter of Intent to Explore Acquisition of Rendiatech Ltd., A Real-Time Fluid Monitoring Company
August 19, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/08/19/3135669/26106/en/nuwellis-signs-letter-of-intent-to-explore-acquisition-of-rendiatech-ltd-a-real-time-fluid-monitoring-company.html
Nuwellis, Inc. Reports Q2 2025 Financial Results
August 15, 2025  |  msn.comhttps://www.msn.com/en-us/money/news/nuwellis-inc-reports-q2-2025-financial-results/ar-AA1Kz12U
Nuwellis, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
August 15, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/08/15/3134202/26106/en/nuwellis-inc-to-present-at-the-webull-financial-corporate-connect-webinar-series-biotech-medtech.html
Nuwellis outlines Q3 recovery and strategic shift after resolving $400,000 back order
August 14, 2025  |  msn.comhttps://www.msn.com/en-us/technology/general/nuwellis-outlines-q3-recovery-and-strategic-shift-after-resolving-400-000-back-order/ar-AA1KxrJF
Nuwellis, Inc. (NUWE) Q2 2025 Earnings Call Transcript
August 14, 2025  |  seekingalpha.comhttps://seekingalpha.com/article/4813796-nuwellis-inc-nuwe-q2-2025-earnings-call-transcript
Nuwellis reports Q2 EPS ($60.99) vs ($791.82) last year
August 14, 2025  |  msn.comhttps://www.msn.com/en-us/money/economy/nuwellis-reports-q2-eps-60-99-vs-791-82-last-year/ar-AA1KxaJZ
Nuwellis, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights
August 14, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/08/14/3133455/26106/en/nuwellis-inc-reports-second-quarter-2025-financial-results-and-business-highlights.html
An Overview of Nuwellis's Earnings
August 13, 2025  |  benzinga.comhttps://www.benzinga.com/insights/earnings/25/08/47097198/an-overview-of-nuwelliss-earnings
Nuwellis to Exit International Operations to Accelerate U.S. Revenue Growth and Strategic Focus
August 7, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/08/07/3129239/26106/en/nuwellis-to-exit-international-operations-to-accelerate-u-s-revenue-growth-and-strategic-focus.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

Allurion Technologies stock logo

Allurion Technologies NYSE:ALUR

$2.16 -0.03 (-1.14%)
Closing price 09/12/2025 03:55 PM Eastern
Extended Trading
$2.18 +0.02 (+0.92%)
As of 09/12/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.

Biotricity stock logo

Biotricity NASDAQ:BTCY

$0.73 0.00 (-0.62%)
As of 09/12/2025 03:49 PM Eastern

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.

Inspira Technologies OXY B.H.N. stock logo

Inspira Technologies OXY B.H.N. NASDAQ:IINN

$1.21 +0.05 (+4.31%)
Closing price 09/12/2025 04:00 PM Eastern
Extended Trading
$1.20 -0.01 (-0.83%)
As of 09/12/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'annana, Israel.

Nuwellis stock logo

Nuwellis NASDAQ:NUWE

$4.18 -0.03 (-0.71%)
Closing price 09/12/2025 04:00 PM Eastern
Extended Trading
$4.20 +0.03 (+0.60%)
As of 09/12/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors in Austria, Belarus, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Panama, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas